Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
Tetsuya Akaishi(Tohoku University Hospital), Ichiro Nakashima(Tohoku Medical and Pharmaceutical University), Ryo Ogawa(Fukushima Medical University), Shuhei Nishiyama(Fukushima Medical University), Toshiyuki Takahashi(Fukushima Medical University), Kimihiko Kaneko(Tohoku University), Kazuo Fujihara(Tohoku University), Masashi Aoki(Tohoku University), Juichi Fujimori(Fukushima Medical University), Tadashi Ishii(Tohoku University Hospital), Yoshiki Takai(Fukushima Medical University), Tatsuro Misu(Tohoku University)
Cited by 90
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740